High expression of lactotriaosylceramide, a differentiation-associated glycosphingolipid, in the bone marrow of acute myeloid leukemia patients

Glycobiology

Volumn 22, Issue 7, 2012, Pages 930-938

  Wang, Zheng ^a   Wen, Lijun ^a   Ma, Xiao ^a   Chen, Zijun ^b   Yu, Yunhui ^a   Zhu, Jian ^a   Wang, Yanping ^a   Liu, Zhenming ^c   Liu, Haiyan ^a   Wu, Depei ^a   Zhou, Dapeng ^d   Li, Yunsen ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute myeloid leukemia; Glycosphingolipidomics; Lactotriaosylceramide; Lc3 synthase; Mass spectrometry

Indexed keywords

BETA1,3 N ACETYLGLUCOSAMINYLTRANSFERASE5; GANGLIOSIDE GM3; GLYCOSPHINGOLIPID; LACTOTRIAOSYLCERAMIDE; N ACETYLGLUCOSAMINYLTRANSFERASE; PARAGLOBOSIDE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; CANCER PATIENT; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; ION TRAP MASS SPECTROMETRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SAMPLE;

BONE MARROW; CARBOHYDRATE CONFORMATION; CASE-CONTROL STUDIES; GENE EXPRESSION; GLOBOSIDES; GLYCOSPHINGOLIPIDS; HUMANS; LACTOSYLCERAMIDES; LEUKEMIA, MYELOID, ACUTE; N-ACETYLGLUCOSAMINYLTRANSFERASES; REFERENCE STANDARDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84861378373     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws061     Document Type: Article

References (43)

1. Ashline D, Singh S, Hanneman A, Reinhold V. 2005. Congruent strategies for carbohydrate sequencing. 1. Mining structural details by MSn. Anal Chem. 77:6250-6262. (Pubitemid 41436960)
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. 1976. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 33 (4):451-458.
3. Biellmann F, Hülsmeier AJ, Zhou D, Cinelli P, Hennet T. 2008. The Lc3-synthase gene B3gnt5 is essential to pre-implantation development of the murine embryo. BMC Dev Biol. 8:109.
4. Bolanos-Meade J, Karp JE, Guo C, Sarkodee-Adoo CB, Rapoport AP, Tidwell ML, Buddharaju LN, Chen TT. 2003. Timed sequential therapy of acute myelogenous leukemia in adults: A phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide. Leuk Res. 27:313-321. (Pubitemid 36071388)
5. Ciucanu I, Costello CE. 2003. Elimination of oxidative degradation during the per-O-methylation of carbohydrates. J Am Chem Soc. 125:16213-16219. (Pubitemid 38020645)
6. Cooling LL, Zhang DS, Naides SJ, Koerner TA. 2003. Glycosphingolipid expression in acute nonlymphocytic leukemia: Common expression of Shiga toxin and parvovirus B19 receptors on early myeloblasts. Blood. 101:711-721. (Pubitemid 36077598)
7. Costello CE. 1999. Bioanalytic applications of mass spectrometry. Curr Opin Biotechnol. 10:22-28. (Pubitemid 29054621)
8. Costello CE, Vath JE. 1990. Tandem mass spectrometry of glycolipids. Methods Enzymol. 193:738-768.
9. Degos L, Wang ZY. 2001. All trans retinoic acid in acute promyelocytic leukemia. Oncogene. 20:7140-7145. (Pubitemid 33107374)
10. Dell A, Morris HR. 2001. Glycoprotein structure determination by mass spectrometry. Science. 291:2351-2356. (Pubitemid 32231789)
11. Hakomori S. 1998. Cancer-associated glycosphingolipid antigens: Their structure, organization, and function. Acta Anat (Basel). 161:79-90. (Pubitemid 28478161)
12. Hakomori S. 2002. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci USA. 99:10231-10233.
13. Hakomori SI. 2008. Structure and function of glycosphingolipids and sphingolipids: Recollections and future trends. Biochim Biophys Acta. 1780:325-346.
14. Harvey DJ. 1999. Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom Rev. 18:349-450.
15. Henion TR, Zhou D, Wolfer DP, Jungalwala FB, Hennet T. 2001. Cloning of a mouse β1,3N-acetylglucosaminyltransferase GlcNAc(β1,3)Gal(β1,4) Glc-ceramide synthase gene encoding the key regulator of lacto-series glycolipid biosynthesis. J Biol Chem. 276:30261-30269.
16. Hinkovska-Galcheva VT, Boxer LA, Mansfield PJ, Harsh D, Blackwood A, Shayman JA. 1998. The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. J Biol Chem. 273:33203-33209. (Pubitemid 29005692)
17. Ichikawa S, Hirabayashi Y. 1998. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 8:198-202. (Pubitemid 28188114)
18. Jarvis WD, Grant S, Kolesnick RN. 1996. Ceramide and the induction of apoptosis. Clin Cancer Res. 2:1-6. (Pubitemid 26042173)
19. Jasek E, Mirecka J, Litwin JA. 2008. Effect of differentiating agents (all-trans retinoic acid and phorbol 12-myristate 13-acetate) on drug sensitivity of HL60 and NB4 cells in vitro. Folia Histochem Cytobiol. 46:323-330.
20. Kasahara K, Sanai Y. 1999. Possible roles of glycosphingolipids in lipid rafts. Biophys Chem. 82:121-127.
21. Levery SB. 2005. Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405:300-369. (Pubitemid 43081964)
22. Li Y, Teneberg S, Thapa P, Bendelac A, Levery SB, Zhou D. 2008. Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry. Glycobiology. 18:158-165. (Pubitemid 351168254)
23. Li Y, Thapa P, Hawke D, Kondo Y, Furukawa K, Hsu FF, Adlercreutz D, Weadge J, Palcic MM, Wang PG, et al. 2009. Immunologic glycosphingolipidomics and NKT cell development in mouse thymus. J Proteome Res. 8:2740-2751.
24. Li Y, Zhou D, Xia C, Wang PG, Levery SB. 2008. Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry. Glycobiology. 18:166-176. (Pubitemid 351168255)
25. Liang YJ, Kuo HH, Lin CH, Chen YY, Yang BC, Cheng YY, Yu AL, Khoo KH, Yu J. 2010. Switching of the core structures of glycosphingolipids from globo-and lacto-to ganglio-series upon human embryonic stem cell differentiation. Proc Natl Acad Sci USA. 107:22564-22569.
26. Liu AH, Liu F, Li Z, Gu JX, Chen HL. 1998. Alterations in glycosyltransferases during myeloid and monocytoid differentiation of HL-60 cells. Cell Biol Int. 22:545-550. (Pubitemid 29346626)
27. McEver RP, Moore KL, Cummings RD. 1995. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem. 270:11025-11028.
28. Nakamura M, Tsunoda A, Sakoe K, Gu J, Nishikawa A, Taniguchi N, Saito M. 1992. Total metabolic flow of glycosphingolipid biosynthesis is regulated by UDP-GlcNAc:lactosylceramide beta 1->3N-acetylglucosaminyltransferase and CMP-NeuAc:lactosylceramide alpha 2->3 sialyltransferase in human hematopoietic cell line HL-60 during differentiation. J Biol Chem. 267:23507-23514. (Pubitemid 23088148)
29. Nozaki H, Yanagida M, Koide K, Shiotani K, Kinoshita M, Kobayashi Y, Watarai S, Nakamura K, Suzuki A, Ariga T, et al. 2010. Production and characterization of monoclonal antibodies specific to lactotriaosylceramide. Glycobiology. 20:1631-1642.
30. Ogasawara N, Katagiri YU, Kiyokawa N, Kaneko T, Sato B, Nakajima H, Miyagawa Y, Kushi Y, Ishida H, Kiso M, et al. 2011. Accelerated biosynthesis of neolacto-series glycosphingolipids in differentiated mouse embryonal carcinoma F9 cells detected by using dodecyl N-acetylglucosaminide as a saccharide primer. J Biochem. 149:321-330.
31. Peter-Katalinic J, Egge H. 1990. Desorption mass spectrometry of glycosphingolipids. Methods Enzymol. 193:713-733.
32. Reinhold VN, Reinhold BB, Costello CE. 1995. Carbohydrate molecular weight profiling, sequence, linkage, and branching data: ES-MS and CID. Anal Chem. 67:1772-1784.
33. Reinhold VN, Sheeley DM. 1998. Detailed characterization of carbohydrate linkage and sequence in an ion trap mass spectrometer: Glycosphingolipids. Anal Biochem. 259:28-33. (Pubitemid 28247046)
34. Saito M. 1993. Bioactive gangliosides: Differentiation inducers for hematopoietic cells and their mechanism(s) of actions. Adv Lipid Res. 25:303-327.
35. Samuelsson BE, Pimlott W, Karlsson KA. 1990. Mass spectrometry of mixtures of intact glycosphingolipids. Methods Enzymol. 193:623-646.
36. Sietsma H, Kamps WA, Dontje B, Hendriks D, Kok JW, Vellenga E, Nijhof W. 1999. Leukemia-induced bone marrow depression: Effects of gangliosides on erythroid cell production. Int J Cancer. 82:92-97. (Pubitemid 29266112)
37. Smolenska-Sym G, Spychalska J, Zdebska E, Wozniak J, Traczyk Z, Pszenna E, Maj S, Danikiewicz W, Bienkowski T, Koscielak J. 2004. Ceramides and glycosphingolipids in maturation process: Leukemic cells as an experimental model. Blood Cells Mol Dis. 33:68-76. (Pubitemid 38829601)
38. Togayachi A, Akashima T, Ookubo R, Kudo T, Nishihara S, Iwasaki H, Natsume A, Mio H, Inokuchi J, Irimura T, et al. 2001. Molecular cloning and characterization of UDP-GlcNAc: Lactosylceramide β1,3-N- acetylglucosaminyltransferase (β3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J Biol Chem. 276: 22032-22040.
39. Togayachi A, Kozono Y, Ikehara Y, Ito H, Suzuki N, Tsunoda Y, Abe S, Sato T, Nakamura K, Suzuki M, et al. 2010. Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation. Proc Natl Acad Sci USA. 107:11900-11905.
40. Vitoux D, Nasr R, de The H. 2007. Acute promyelocytic leukemia: New issues on pathogenesis and treatment response. Int J Biochem Cell Biol. 39:1063-1070. (Pubitemid 46819138)
41. Wennekes T, van den Berg RJ, Boot RG, van der Marel GA, Overkleeft HS, Aerts JM. 2009. Glycosphingolipids-nature, function, and pharmacological modulation. Angew Chem Int Ed Engl. 48:8848-8869.
42. Yu RK. 1994. Development regulation of ganglioside metabolism. Prog Brain Res. 101:31-44. (Pubitemid 24084736)
43. Zhou D, Mattner J, Cantu C, 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science. 306(5702):1786-1789. (Pubitemid 39601398)